Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors [clinicaltrials:NCT02453542]
Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors [clinicaltrials:NCT02453542]
Bio2RDF identifier
NCT02453542
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT02453542
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
authority [clinicaltrials_vocabulary:authority]
biospec retention [clinicaltrials_vocabulary:biospec-retention]
Samples Without DNA
biospec_descr [clinicaltrials_vocabulary:biospec_descr]
whole blood
brief summary [clinicaltrials_vocabulary:brief-summary]
Background
The t ...... the titers of the inhibitors.
brief title [clinicaltrials_vocabulary:brief-title]
Global Haemostatic Methods Fol ...... th Haemophilia With Inhibitors
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2015-05-17T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
keyword [clinicaltrials_vocabulary:keyword]
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2015-05-22T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT02453542
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
Global Haemostatic Methods to ...... th Haemophilia With Inhibitors
org study id [clinicaltrials_vocabulary:org-study-id]
202100-2973
overall contact [clinicaltrials_vocabulary:overall-contact]
overall contact backup [clinicaltrials_vocabulary:overall-contact-backup]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2018-06-01T00:00:00Z
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2015-03-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
target duration [clinicaltrials_vocabulary:target-duration]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2015-05-01T00:00:00Z
identifier
clinicaltrials:NCT02453542
title
Global Haemostatic Methods Fol ...... th Haemophilia With Inhibitors
@en
type
label
Global Haemostatic Methods Fol ...... s [clinicaltrials:NCT02453542]
@en